David Coghlan Becomes Managing Director For Havok

Facebooktwittergoogle_pluspinterestmail

Havok, the Emmy Award winning Irish technology company, has appointed David Coghlan as Managing Director, with effect from June. David Coghlan, who has worked for Havok for the past six years, is an executive member of Havok’s Board of Directors and currently oversees Havok’s commercial operations globally.

Renee James, Senior Vice President, Intel Corporation and Chairman of Havok, says "David Coghlan has been a key contributor to the success and growth of Havok for the past six years as a senior manager and as a member of the Board. Intel is committed to maintaining Havok’s status as an independent subsidiary, because it is clear that this structure gives the company the financial and operating independence to continue to innovate and be successful in the games industry. We are excited to see Havok continue to develop and grow through David’s leadership."

David Coghlan added: "During the past six years, I have had the pleasure of being involved in making Havok a unique success story in the games industry. Havok is committed to building on our position as the leading provider of games middleware technology. We will continue to invest in innovation to deliver cutting edge solutions to the world’s leading games and entertainment companies. I look forward to leading Havok through the next stage in its growth and I am excited by the opportunity to expand the reach of the Havok product line into new gaming genres, new hardware platforms, emerging geographic markets and adjacent industries."

David Coghlan joined Havok in 2004 and has held a number of senior operational roles in the company, including Senior Vice President of Commercial Operations, Vice President of Development and Chief Financial Officer. He has served alongside the outbound Managing Director, David O’Meara, as one of the two executive Directors of the Board since 2007.

Prior to joining Havok, David Coghlan was Director of Corporate Strategy for Elan Corporation, a NYSE-listed biotechnology company. David qualified as an accountant in the audit and business advisory group of international firm, KPMG and he holds a first class honors degree in Finance from Trinity College, Dublin.

Leave a Reply

Your email address will not be published. Required fields are marked *